circulating tumor DNA in the immediate post-operative setting

BACKGROUND: Circulating tumor DNA (ctDNA) has emerged as an accurate real-time biomarker of disease status across most solid tumor types. Most studies evaluating the utility of ctDNA have focused on time points weeks to months after surgery, which for many cancer types, is significantly later than d...

Descripción completa

Detalles Bibliográficos
Autores principales: Efthymiou, Vasileios, Queenan, Natalia, Haas, Markus, Naegele, Saskia, Goss, Deborah, Faden, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593016/
https://www.ncbi.nlm.nih.gov/pubmed/37873394
http://dx.doi.org/10.1101/2023.09.30.23296390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593016/
https://www.ncbi.nlm.nih.gov/pubmed/37873394
http://dx.doi.org/10.1101/2023.09.30.23296390

Ejemplares similares